Home > Maligne hematologie > Lymfoïde ziekten > Acute lymfatische leukemie (ALL) en lymfoblastair lymfoom (LBL) > AMG360

AMG360

Phase 3 Randomized, Controlled Study of Blinatumomab Alternating With Low-intensity Chemotherapy Versus Standard of Care for Older Adults With Newly Diagnosed Philadelphia-negative B-cell Precursor Acute Lymphoblastic Leukemia With Safety Run-in (Golden Gate Study)

Deze print is 24 uur geldig na het aanmaken. Aangemaakt op: 27-4-2024, 18:56